CS Paper Radar

Detection and Validation of Hidden Subgroup Disparities in Clinical AI

Alceu Bissoto, Trung-Dung Hoang, Tim Flühmann, Nina Weng, Susu Sun, Christian F. Baumgartner, Lisa M. Koch

cs.LG ·submitted 2026-10-23 08:54 UTC · v1

Abstract

Machine learning (ML) models used in clinical workflows often perform systematically differently across patient groups, raising concerns about equity and patient safety. Traditional subgroup analyses can expose such disparities only when rich metadata (e.g., patient demographics) is available and captures the sources of performance variation, conditions rarely met in practice. Algorithmic subgroup discovery methods offer a solution by identifying coherent groups from learned feature representations, but because true underlying stratifications are unknown, these methods are hard to evaluate. As a result, subgroup discovery has not been systematically applied or assessed for performance monitoring. Our main objective is to evaluate algorithmic subgroup discovery for performance monitoring, assessing the discovered subgroups' performance gaps and semantic coherence. Investigating cardiomegaly classification in a dataset of 223,228 chest X-rays, we showed that the discovered subgroups exhibited larger performance gaps (accuracies of 0.61-0.90) than traditional metadata-based analysis (0.80-0.94) and were frequently interpretable using patient, acquisition, and model metadata. As a proof of concept, we also showed that annotations from learned subgroups can be used to mitigate the biases they expose. We conclude that subgroup discovery is a practical and effective tool to enhance the performance validation and monitoring of ML systems in healthcare.

Closest papers

Nearest neighbours by meaning across the whole index.

Learning Across Heterogeneous Feature Spaces with Group Robustness

cs.LG ·2026-11-06 ·Xenia Konti, Arjun Tschand, Chuan Hong, Nicoleta J. Economou-Zavlanos, Michael M. Zavlanos
hot direction similarity 0.62
Abstract · 29 pages, 5 figures

In clinical applications, patients undergo different combinations of tests, and machine learning models must therefore ensure accurate predictions across heterogeneous feature spaces. Current approaches upweight the patients with the highest loss, without accounting for the limited predictive information in their features preventing their loss from going any lower. Moreover, when patients' feature spaces are fully disjoint, current methods reduce to training independent models, preventing knowledge transfer across them. We propose a framework for group robust learning across heterogeneous feature spaces, where groups are patients sharing a feature space. Since a high loss may simply reflect uninformative features, we instead optimize for worst-group excess loss, the gap between a group's loss and an estimate of its achievable optimum. To allow collaboration between groups, we use group-specific encoders mapping into a shared latent space in which learnable Gaussian anchors cluster patients by outcome. On tabular and imaging medical datasets, including fully disjoint feature settings, our framework outperforms state-of-the-art methods when groups differ in their optimal losses or cannot train a good model on their own, reducing worst-group loss by up to 79% and excess loss by up to 95% with up to 18$\times$ fewer parameters.

0.34

CareGraph: An Auditable Hybrid AI Framework for Evidence-Grounded Personalized Longitudinal Health Intelligence

cs.AI cs.IRcs.MA ·2026-08-25 ·Pratik Ghawate, Tanvi Patil
benchmarkcode/data similarity 0.62
Abstract · 21 pages, 7 figures, Code and data: https://github.com/PratikGhawate/ai-personalized-health-intelligence

Artificial intelligence is transforming personalized healthcare, yet fragmented clinical, self reported, and wearable evidence remains difficult to interpret and trace. We present CareGraph, an auditable hybrid AI framework that converts heterogeneous records into prioritized trends, missing context indicators, bounded next steps, discussion questions, and provenance linked explanations. CareGraph organizes evidence without diagnosing, predicting outcomes, selecting treatment, or making autonomous clinical decisions. Its pipeline covers deterministic analysis, context detection, graph construction, constrained language model synthesis, evidence validation, safety controls, and release gating. Tests used synthetic cohorts of 400 patients each for development, validation, and holdout. On holdout data, a frozen ordinary least squares trend rule with a sufficiency gate achieved 0.827 accuracy, 0.837 macro F1 with a 95 percent confidence interval of 0.819 to 0.854, and 0.974 insufficient data F1. Missing context detection achieved 0.815 strict micro F1 versus 0.318 for the legacy detector. On an authored holdout benchmark, safety ruleset version 1.2 achieved 1.000 precision, 0.950 recall, and 0.974 F1. An audit requiring graph retrieval across 80 patients yielded 79 syntheses and 78 presentations without fallback; one output was blocked and one failed closed because of an invalid evidence key. Against monolithic GPT 5.6 on 56 matched patients, CareGraph was faster at 40.15 versus 49.62 seconds, shorter at 661 versus 1,163 words, and showed better exploratory lexical alignment with longitudinal targets; the baseline used fewer tokens and cited more raw evidence. Graph auditing verified provenance and deterministic retrieval; incremental graph effects on generation require paired evaluation. CareGraph offers a safety bounded foundation for intelligent personalized health systems.

0.42

Target Recoverability under Selective Labels: A Failure Mode in ECG-Based Acute Coronary Syndrome Prediction

cs.LG cs.AI ·2026-11-08 ·Alexander Schubert, Anton Håkansson, Ziad Obermeyer
top venue similarity 0.62
Abstract · Accepted to the Proceedings of Machine Learning for Health (ML4H) 2026

Medical machine learning models often learn from diagnoses observed only in patients clinicians chose to test. The biases of such selective labels are well known, but less understood is what happens when a diagnosis includes cases the model's inputs cannot detect. Because testing decisions draw on information the model does not see, these cases can appear predictable among tested patients, producing relationships that fail, and can even reverse, among the untested. We formalize this mechanism and show in simulations that it worsens as testing becomes more selective or undetectable cases more common, while models trained only on detectable cases remain informative. We empirically study electrocardiogram (ECG)-based prediction of acute coronary syndrome (ACS), which is confirmed only by invasive testing and whose subtypes differ in how clearly they appear on the ECG. Three ECG foundation models fine-tuned on revascularization, our ACS proxy, performed well among catheterized patients (AUROC 0.740-0.770) but worse than chance for 30-day major adverse cardiovascular events among untested patients (AUROC 0.381-0.478). Models trained on ECG-visible subtypes retained discrimination (AUROC 0.680-0.709), whereas a model trained on unstable angina, which can occur without ECG changes, was inversely related to risk (AUROC 0.310). Under selective labels, effective learning therefore requires prediction targets that can be inferred from the model's inputs and evaluation in the intended deployment population, which often extends beyond the patients who were tested.

0.31

Auditing evaluation artifacts and data leakage in large language model systems for rare disease diagnosis

cs.AI ·2026-10-24 ·Jian Yang, Peilin Liu, Xiaohan Li, Songda Li, Yu Cao +2 more
benchmark similarity 0.61
Abstract · 18 page, 3 figures

Augmented large language model (LLM) systems have reported high benchmark accuracies in rare disease diagnosis, yet their real-world clinical utility remains unproven. A recent meta-analysis flagged augmented LLM diagnostic evaluations as having a high risk of bias due to suspected data leakage; however, the precise impact of these vulnerabilities on model inference has yet to be fully quantified. In this study, we present a comprehensive empirical audit to quantify evaluation artifacts across prevailing AI paradigms, using a repository of over 60,000 cases from diverse public and independent clinical cohorts. By reconstructing a state-of-the-art agentic framework, we demonstrate that candidate-space contamination artificially inflates performance: enforcing strict cross-dataset isolation resulted in a marked performance decline, with the cross-dataset mean Recall@1 decreasing from 54.3% (under conventional one-vs-rest evaluation) to 40.3% (Hedges' g = 0.94). Similar spatial overfitting in supervised classifiers caused diagnostic accuracy to drop from an internal mean of 42.9% to 16.7% across external cohorts (Cohen's d = 2.01). Furthermore, we quantify how LLMs infer diagnoses by exploiting retrospective therapeutic cues in clinical narratives, and how temporal misalignment in foundational knowledge bases leads to performance fluctuations. We conclude that prevailing evaluation protocols for augmented LLM systems inadvertently reflect data leakage rather than genuine medical reasoning. To address these systematic artifacts, we propose a rigorous evaluation framework - coupling strict data-isolation protocols with standardized benchmarking safeguards - to ensure future diagnostic AI for rare diseases is evaluated on actual clinical robustness.

0.50

Glyph: An Interpretability Engine for AI-Driven Scientific Discovery in Clinical Data

cs.AI ·2026-11-06 ·Robbie Holland, Ashwin Kumar, Mateus A. Esmeraldo, David Le, Andrea Fisher +17 more
code/data similarity 0.61
Abstract

Automated scientific discovery has the potential to advance understanding of disease mechanisms and accelerate identification of early disease markers. Manual data annotation is infeasible at population scale, motivating methods that automatically extract pre-defined phenotypes in multimodal and unstructured clinical data. Such pre-defined feature sets determine and limit which associations these approaches can discover. This limitation extends to agentic AI systems that use these tools to query population-scale data. In contrast, foundation models (FMs) trained on large volumes of clinical data can perform tasks beyond their training objectives. This suggests their latent embeddings may represent novel or unexplored features that could yield insights into disease mechanisms, yet such latent features remain difficult to interpret. To address this challenge, we introduce Glyph, an automated multistage framework that extracts features from multimodal and unstructured clinical data using FMs and sparse autoencoders, interprets them as coded clinical concepts, and evaluates their value for clinical scientific discovery. We applied Glyph to abdominal CT volumes, CT radiology reports and laboratory measurements from 41,628 patients across different institutions. We identified 397 predictive concepts supported by 4,463 Bonferroni-significant associations. Moreover, a majority of discovered associations were automatically reproducible in held-out cohorts across different sites. Glyph concepts provided complementary associations to literature-derived markers, leading to gains in predictive power. We envision that interpretability can extend beyond a mechanistic understanding of neural networks to connecting implicitly learned features with clinical knowledge and establishing their significance for patient outcomes. We release Glyph at https://github.com/StanfordMIMI/Glyph.

0.40

Rethinking How We Evaluate Methodological Progress in Health AI

cs.LG cs.AI ·2026-09-16 ·Florent Pollet, Matthew McDermott
similarity 0.60
Abstract

Methodological progress in artificial intelligence (AI) for electronic health records (EHRs) depends on our ability to determine which algorithms work better, and under which conditions. However, such progress is thought to be hindered by difficulties in reproducibility and in defining clinically meaningful evaluation tasks. We empirically study these barriers by re-implementing 12 historical and recent algorithms within a shared evaluation framework and evaluating them on two clinical datasets, MIMIC-IV and NWICU. We compare two complementary task families: expert-authored clinically meaningful tasks and generated tasks defined from randomly sampled event codes and prediction horizons. We ask whether relative algorithms comparisons transfer across task families and datasets, whether residual task heterogeneity contains useful methodological structure, and what a controlled comparison reveals about progress over the last decade. We find that aggregate pairwise comparisons transfer strongly across evaluation settings, including from randomly generated tasks to clinically meaningful tasks and across datasets. At the same time, clinically meaningful tasks exhibit greater task-method interaction, providing preliminary evidence that task properties can help explain when particular modeling choices are advantageous. Finally, newer algorithms do not consistently outperform earlier approaches: gradient-boosted trees remain highly competitive when paired with a modern, wide and sparse representation of the EHR. Together, these results suggest that useful methodological knowledge may require less task engineering than commonly assumed, while highlighting the importance of understanding the structured heterogeneity that remains across tasks and methods.

0.42

Hidden Data Challenges in Clinical Machine Learning

cs.LG ·2026-10-09 ·Carolin Cissée, Dennis Fast, Raneen Younis, Alexander Löser, Wolfgang Nejdl +1 more
code/data similarity 0.60
Abstract

Widely reused preprocessing pipelines for electronic health records can encode assumptions about when information became available, what clinical episode a label represents, and what missingness means. These assumptions are rarely audited systematically and may propagate across subsequent studies when preprocessing pipelines are reused or adapted. Using MIMIC-IV as a case study, we identify and quantify violations of three complementary forms of preprocessing alignment, i.e., temporal, semantic, and population alignment, which manifest as temporal leakage, feature-task misalignment, and biased imputation. We show how ambiguities in timestamp semantics, episode definitions, endpoint construction, modality selection, and missingness handling can alter the information available to a model and affect the interpretation of its predictions. Through analyses of MIMIC-IV data and empirical case studies, we demonstrate that such choices may remain largely invisible in aggregate predictive performance while changing the signals on which models rely. We derive practical recommendations for temporally valid, clinically aligned, and reproducible preprocessing of MIMIC-IV and related electronic health record datasets. The code for our experiments, including our proposed preprocessing, is available at: https://github.com/m2l-lab/mimic-iv-preprocess.

0.22

FairGlucose: A CGM Fairness Benchmark Reveals Subgroup Disparities Hidden in Population-Level Validation

cs.CY cs.AI ·2026-08-18 ·Junjie Luo, Xuzhe Zhi, Rui Han, Abhimanyu Kumbara, Anand K. Iyer +3 more
benchmark similarity 0.60
Abstract

As CGM-based AI tools approach clinical deployment, whether their accuracy is equitable across patient demographics remains insufficiently tested. To enable this evaluation, we constructed FairGlucose, a 300-patient CGM cohort balanced across 12 demographic strata (age x gender x type 1/type 2 diabetes), with 132,480 forecasting samples and 3,945 unique behavioral events (meals, exercise, medication) logged by 81 patients. Benchmarking 33 models across four families on 2-hour glucose forecasting, we find that population-level external validation can conceal substantial subgroup disparities. Aggregate out-of-distribution metrics appear stable (approximately 1.0), yet subgroup-level ratios range from 0.8 to 1.4, with T1D patients showing 6 mg/dL higher prediction error than T2D (p < 0.001). This disparity persists across all 33 models, suggesting a property of the prediction task rather than any single architecture. Further analysis shows that subgroup performance gaps align with the proportion of clinically hard cases, and that input-length sensitivity varies across demographics, motivating personalized configurations. Frontier LLMs underperform specialized neural models by 1-6 mg/dL; behavioral events contribute negligibly (approximately 0.1 mg/dL) even under oracle event access. These findings establish that population-level validation alone is insufficient for equity assessment of digital health AI, motivating subgroup-disaggregated reporting as a default standard.

0.29